This research aims to identify differential metabolic signatures associated with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) to improve risk assessment and treatment strategies.
Prospective international multi-ethnic cohort study
Analysis of metabolic signatures associated with HFpEF and HFrEF
Focus on metabolic inflammation and energy metabolism pathways
Identified distinct metabolic profiles for HFpEF and HFrEF patients
Enhanced risk stratification based on metabolic signatures
Highlighted potential therapeutic targets for intervention
Abstract
Differential metabolic signatures tied to metabolic inflammation in HFpEF and impaired energy metabolism in HFrEF enhance risk stratification and point to therapeutic targets.